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Conclusions: Lower knee conﬁdence was associated with worse physi-
cal function in persons with or at risk for knee OA. This relationship was
partially attenuated after adjusting for pain severity, but not after adjusting
for other factors. These results introduce the possibility that conﬁdence
may play a pivotal role in the path to function decline; awareness of this
and attention to it may help to prevent poor outcome.
Epidemiology & Health Services Research
307 THE RELATIONSHIP OF WEIGHT CHANGE WITH CHANGES
IN KNEE PAIN AND FUNCTION IN PERSONS WITH
SYMPTOMATIC RADIOGRAPHIC KNEE OSTEOARTHRITIS:
DATA FROM THE OSTEOARTHRITIS INITIATIVE
T. Niculescu1, K. Favors1, J.D. Sorkin1, S. Bartlett2, J.M. Bathon2,
M.C. Hochberg1. 1University of Maryland, Baltimore, MD, USA, 2The
Johns Hopkins University, Baltimore, MD, USA
Purpose: Overweight is a major risk factor for the development and
progression of knee osteoarthritis (OA) and weight loss is recommended
by OARSI as part of the non-pharmacologic management of patients
with knee OA. This analysis examined the relationship between weight
change and change in self-reported symptoms and function and physical
performance in adults with symptomatic radiographic knee OA over one
year.
Methods: Data for these analyses were obtained from the Osteoarthri-
tis Initiative (OAI) database, which is available for public access at
<http://www.oai.ucsf.edu/>. Speciﬁcally, we examined data from the base-
line and 12-month follow-up visits for 711 subjects with symptomatic
radiographic knee OA enrolled in the Progression subcohort. All subjects
completed the Western Ontario McMaster Osteoarthritis Index (WOMAC)
and Knee Osteoarthritis Outcome Scale (KOOS) at both visits. Weight
was measured with a balance beam scale, height was measured with a
stadiometer and physical performance was measured with a timed 20-
meter walk. Names and dosage of medications and supplements were
recorded at both clinic visits by trained personnel. Correlations between
change in weight and outcomes were examined in unadjusted and
multiple variable adjusted models using generalized estimating equations
to control for the correlation between knees in subjects with more than
one involved knee at baseline. In addition, subjects were categorized
into tertiles based on weight change and the change in outcomes was
examined across tertiles using analysis of variance.
Table 1: Correlation Coefﬁcients of Weight Change with Selected Outcomes
Outcome Unadjusted
analysis
Multiple variable
adjusted
analysis
WOMAC Pain Scale −0.031 −0.032
WOMAC Function Scale 0.033 0.029
WOMAC Total 0.021 0.019
KOOS Symptom Scale 0.004 0.003
KOOS Pain Scale −0.001 0.002
KOOS Function Scale −0.026 −0.029
KOOS Quality of Life −0.025 −0.023
20-meter Walk Speed −0.099* −0.098*
*P< 0.01
Table 2: Change in Weight and Selected Outcomes (mean [SD]) by Tertile of Weight Change
Outcome Variable Weight gain
N=242
Weight stable
N=223
Weight loss
N=246
Weight change, kg 3.36 (2.9) 0.14 (0.6) −4.01 (3.9)
Change in WOMAC Pain −0.87 (3.1) −0.42 (3.0) −0.48 (2.9)
Change in WOMAC Function −1.87 (9.1) −2.09 (9.3) −1.74 (9.6)
Change in WOMAC Stiffness −0.24 (1.6) −0.42 (1.7) −0.11 (1.5)
Change in WOMAC Total Score −3.06 (12.3) −2.92 (12.3) −2.36 (12.6)
Change in KOOS Pain 4.65 (14.9) 3.52 (15.4) 3.29 (14.3)
Change in KOOS Function 5.19 (22.4) 1.66 (21.4) 3.57 (16.0)
Change in KOOS Symptoms 2.55 (12.6) 4.23 (14.1) 1.03 (13.4)
Change in KOOS VAS Symptoms −0.55 (2.6) −0.27 (2.5) −0.27 (2.0)
Change in KOOS Quality of Life 4.00 (17.3) 2.86 (17.4) 4.27 (15.8)
Change in KOOS VAS Quality of Life −0.40 (2.1) 0.23 (2.1) −0.33 (2.0)
Change in Walking Speed, m/sec −0.02 (0.16) −0.01 (0.15) 0.01 (0.14)
Results: At entry, the 711 subjects had a mean (SD) age of 61.8 (9.4)
years; 422 (59.4%) were women and 582 (81.9%) were white. The mean
weight, height and body mass index (BMI) were 85.0 (16.7) kg, 1.68 (0.09)
meters and 30.0 (4.9) kg/m2, respectively. One-third had bilateral symp-
tomatic radiographic knee OA. Over an average of 12 months, the mean
(SD) weight change was −0.20 (4.07) kg: mean (SD) weight change was
−4.01 (3.9), 0.14 (0.6) and 3.36 (2.9) kg for the tertile that lost weight, had
stable weight and gained weight, respectively. In unadjusted analyses,
the only signiﬁcant correlation of weight change with symptomatic and
functional outcomes was with the 20-meter walking speed: R=−0.099,
P< 0.01. This correlation remained signiﬁcant after adjustment for age,
gender, race, baseline BMI and use of analgesic and/or antiinﬂammatory
medications at both visits (see Table 1). Analyses comparing change in
symptomatic and functional outcomes across tertiles, failed to demon-
strate signiﬁcant trends across groups based on weight change (see
Table 2).
Conclusions: These data, from a subset of participants with symptomatic
radiographic knee OA in the OAI, demonstrate a signiﬁcant inverse corre-
lation between weight change and change in walking speed, a measure
of physical performance, but fail to demonstrate signiﬁcant correlations
between weight change and changes in self-reported symptoms and
function. Further analyses will explore the relationship between weight
change and change in structural outcomes assessed with ﬁxed ﬂexion
knee radiographs and magnetic resonance imaging.
308 THE PREVALENCE OF KNEE AND HIP OSTEOARTHRITIS IN
SWEDEN: RESULTS FROM A POPULATION-BASED HEALTH
CARE REGISTRY
M. Englund, D. Noreen, T. Lithman, I.F. Petersson. Lund University,
Lund, SWEDEN
Purpose: In the study of osteoarthritis (OA) and its impact on society it is
important to have up-to-date prevalence estimates. Due to the Swedish
health care system, where all residents are insured and the computerized
registration of all clinic visits including diagnosis as given by the physician,
we can obtain information on disease occurance in a intrigue fashion.
Thus, our objective was to determine the prevalence knee and hip OA in
southern Sweden.
Methods: In Sweden all residents are insured and entitled to health
care. By law all in- and outpatient health care provided to residents is
prospectively registered by the individual’s unique identiﬁcation number,
which also provides information on date of birth and sex. Other types of
data that are registered include date of visit, the health care provider, and
diagnosis code according to the International Classiﬁcation of Diseases
and Related Health Problems (ICD-10) system. We identiﬁed all residents
having received an ICD-10 diagnosis code of knee OA (M17) or hip
OA (M16) at a clinic visit to a physician between January 1, 2000 and
December 31, 2006 in the southernmost region of Sweden. Estimates
of point prevalence were obtained by cross-referencing personal identi-
ﬁcation numbers with those from the National Population Registry (total
population in the region = 1,184,500). Individuals that have had a clinic
visit in the period with a hip or knee OA diagnosis code that were
deceased or had relocated out of the region by December 31, 2006
(no longer in the National Population Registry) were excluded from the
nominator. We deﬁned the individuals’ age by their age 2006.
Results: The point prevalence of diagnosed knee and hip OA among
residents of southern Sweden across all ages was 2.02% (95%CI 2.00,
2.05) and 1.08% (95%CI 1.07, 1.10), respectively. The peak prevalence
of diagnosed knee and hip OA in women and men, respectively, was
found in individuals aged 74 to 85 years (table 1, ﬁgure 1).
Conclusions: These OA prevalence ﬁgures derived from actual health
care seeking individuals demonstrate the potential burden of the disease
on society. The age- and sex-speciﬁc characteristics of the estimates are
typical of those patterns previously reported supporting external validity
of these registry data. Importantly, these ﬁgures should be considered
conservative estimates of the “true” OA prevalence. Remembering, they
only reﬂect individuals symptomatic enough to seek health care and get
an OA diagnosis. The estimates do not include individuals that do not
seek health care, e.g., they self-medicate or individuals that do seek
health care but only received an unspeciﬁc ICD-10 code for their clinic
visit(s).
Table 1: Prevalence of knee and hip osteoarthritis (OA) in men and women aged 75 to 84 years
Location Prevalence (95%CI)
Men Women
Knee OA 6.5% (6.2, 6.8) 9.1% (8.8, 9.4)
Hip OA 5.2% (4.9, 5.4) 5.6% (5.4, 5.8)
